Thrombin-Activatable Fibrinolysis Inhibitor in Human Abdominal Aortic Aneurysm Disease

Article English OPEN
Bridge, KI; Bollen, L; Zhong, J; Hesketh, M; Macrae, FL; Johnson, A; Philippou, H; Scott, DJ; Gils, A; Ariёns, RAS;
  • Publisher: Wiley

Background: Intra-luminal thrombosis is a key factor in Abdominal Aortic Aneurysms (AAA) growth. Patients with AAA form dense clots that are resistant to fibrinolysis. Thrombin-activatable fibrinolysis inhibitor (TAFI) has been shown to influence AAA development in muri... View more
Share - Bookmark